Cardiac Rehabilitation Following Myocardial Infarction  by West, Robert R.
As we stated in our discussion, the 0.4% absolute difference in
mortality between patients with and without myocardial infarction
(MI) after successful intervention could still be clinically meaning-
ful. But we must reject the other criticisms of Dr. Ioannidis and
colleagues regarding the limitations of our study. The inferences
are not based on a small number of unsuccessful procedures, but on
an analysis of 5,850 patients with over 100 deaths, for which an
unsuccessful procedure was one of the most significant indepen-
dent predictors of one-year mortality. Most importantly, we are
concerned with the misinterpretation of our identification of
successful and unsuccessful procedures. We were careful to select
unsuccessful procedures using criteria on which most operators
would concur in the context of current stenting techniques. We
agree many would choose to broaden these criteria and thus further
purify the successful group. Regardless of where this line of success
is drawn, however, it is clear that the effect of CK-MB elevation
among truly successful procedures in this patient cohort would be
small to nonexistent.
We also agree that this finding is worth validating in larger
numbers of patients. Doing so will require access to databases
where the pre-procedure risk and results of successful and unsuc-
cessful procedures are clearly identified, thereby avoiding unnec-
essary panic among patients and their physicians when small
elevations in CK-MB are detected following an otherwise success-
ful procedure.
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Cardiac Rehabilitation
Following Myocardial Infarction
In an observational study Witt et al. (1) report a striking survival
advantage among patients attending cardiac rehabilitation. They
employ a rather unusual adjustment to compare patients of very
different ages, a “propensity to attend cardiac rehabilitation” rather
than the more usual inclusion of prognostic risk factors in
multivariate analyses.
Their findings are not borne out by randomized trials. In
discussion, they comment that early (small) trials may not be
generalized to contemporary practice. Too true. Pooling of all trials
undertaken since the World Health Organization European col-
laborative (but excluding ours, see the next sentence) show collec-
tively no significant effect on mortality (2). The only multicenter
trial undertaken since widespread use of thrombolysis, aspirin,
beta-blocker, angiotensin-converting enzyme inhibitor, and statin
shows no effect on mortality (3).
*Robert R. West, MA, PhD, FSS, FFPHM
*Wales Heart Research Institute
Heath Park
Cardiff
CF14 4XN Wales
United Kingdom
E-mail: WestRR@cardiff.ac.uk
doi:10.1016/j.jacc.2005.03.009
REFERENCES
1. Witt BJ, Jacobsen SJ, Weston SA, et al. Cardiac rehabilitation after
myocardial infarction in the community. J Am Coll Cardiol 2004;44:
988–96.
2. West RR. Cardiac rehabilitation: to reduce mortality and morbidity or
to improve quality of medical care. Eur J Cardiovasc Prev Rehab
2004;11 Suppl 1:87.
3. West RR, Beswick AD. Mortality, morbidity and quality of life
following cardiac rehabilitation: results of multicentre randomised
controlled trial. J Am Coll Cardiol 2002;39 Suppl B:453B.
REPLY
We appreciate the interest of Dr. West in our work (1). We
respectfully take issue with the statement that the use of
propensity-score methodology is unusual. Indeed, the use of
propensity score is a commonly used, well-accepted method of
statistical adjustment (2,3). It is considered by many to be
preferable to conventional regression analysis to adjust for differ-
ences in baseline characteristics and control for confounding by
indication. As in any observational study, however, we cannot rule
out residual confounding related to unmeasured characteristics.
This point, which was emphasized in our report, is important to
underscore in the interpretation of our data.
As underscored by Dr. West, and as stated in our study,
randomized controlled trials constitute the methodological gold
standard to test the effect of an intervention. Dr. West quotes one
meta-analysis of four trials (4) and one multicenter randomized
trial (4). Both of these are published only in abstract format, and
neither one provides sufficient information to interpret the find-
ings. For example, the trial inclusion criteria or components of the
rehabilitation programs may be substantially different from what is
reported in our community-based myocardial incidence cohort (1).
These differences could, in turn, explain the observed differences in
survival. More importantly, the duration of follow-up in the
randomized trial is only 12 months (5), shorter than in our
published follow-up of 6.6 years (1). Finally, the apparent age and
gender disparities in the delivery of care noted in our analysis could
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